Ohio Patent of the Month – February 2024

The field of sleep medicine is witnessing a groundbreaking development in the treatment of sleep-related breathing disorders, thanks to the innovative approach pioneered by Cleveland Medical Devices Inc. (CleveMed). The company’s newly patented technology combines diagnostics and treatment seamlessly, providing a comprehensive solution for individuals suffering from sleep apnea.

The core of this inventive system lies in its ability to collect and analyze a rich set of physiological data from subjects, even in the comfort of their homes. CleveMed’s data acquisition system employs various sensors to monitor crucial parameters like respiratory effort, pulse oximetry, and airflow during sleep. The integration of multiple sensors enables a thorough understanding of the subject’s sleep patterns and the severity of their sleep apnea.

A key element of this system is its compatibility with positive airway pressure (PAP) devices, such as continuous positive airway pressure (CPAP). The CPAP device is equipped with advanced electronics and wireless connectivity to receive signals from the data acquisition system in real-time. This allows for an automatic adjustment or titration of the CPAP device based on the physiological signals collected, ensuring an optimized treatment tailored to the individual’s needs.

The wireless capabilities extend beyond the immediate connection between the data acquisition system and the CPAP device. CleveMed’s system introduces the concept of remote monitoring, where collected data is transmitted to a remote station. Medical personnel can remotely review the data, providing an opportunity for real-time adjustments to the CPAP device. This innovative approach not only enhances the efficiency of treatment but also facilitates proactive interventions based on the continuous monitoring of a subject’s sleep-related breathing disorder.

The versatility of this system is further highlighted by its potential applications in diagnosing and treating different types of sleep apnea, including obstructive, central, and complex sleep apneas. The integration of a respiratory effort belt sensor, pulse oximetry sensor, and additional third sensors adds depth to the diagnostic capabilities, allowing for a comprehensive evaluation of the subject’s condition.

CleveMed’s invention not only transforms the treatment landscape for sleep-related breathing disorders but also sets a new standard for the integration of diagnostics and therapy. This method not only improves the accuracy of titration but also enhances the overall effectiveness of sleep apnea treatment. As this innovative system continues to evolve, it holds the promise of improving the quality of life for millions of individuals affected by sleep-related breathing disorders.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Recent Posts